Latest Price Spikes News

Genesis Energy's FY25 Q2 report highlights a strategic pivot towards renewable energy and enhanced portfolio flexibility, marked by the Lauriston solar farm's early generation and a sharp cut in carbon emissions, even as total generation declined.

Contact Energy's December 2024 report reveals a nuanced performance with slightly lower mass market sales but stronger netback prices and significantly reduced generation costs, underscoring operational efficiencies amid evolving market dynamics.

Contact Energy has secured a pivotal gas supply contract with OMV for the Pohokura field, ensuring fuel for its gas peaking units through 2032 despite soaring gas prices and operational costs.

Nimy Resources has addressed an ASX inquiry regarding recent spikes in its share price and trading volume, confirming no undisclosed information but highlighting ongoing work on its maiden JORC Exploration Target for gallium.

Wellard Limited has disclosed the binding sale of its last livestock vessel, the M/V Ocean Drover, for US$50 million, with plans to return the net proceeds to shareholders pending approval.

Artrya Limited has responded to an ASX price query following a notable surge in its share price, confirming no undisclosed information and adherence to continuous disclosure rules.

Resources & Energy Group Ltd (REZ) has clarified recent trading activity in its shares, attributing the surge to a significant rise in gold prices rather than undisclosed information. The company remains focused on its Maranoa gold recovery program, with further results pending.

First Graphene Limited has responded to an ASX price query, attributing its recent share price and volume surge to increased buying activity in Germany linked to prior commercial announcements, while reaffirming full compliance with ASX disclosure rules.

Latrobe Magnesium Limited has responded to an ASX price query, denying any undisclosed information that could explain the recent sharp drop in its share price and surge in trading volume.

EBR Systems Inc. has responded to ASX's price query, denying any undisclosed information behind recent trading spikes and confirming compliance with listing rules. The company also flagged an upcoming FDA inspection announcement.